Anti-ICOS/CD278 Antibody (Feladilimab)
Catalog No.
F1497
Anti-ICOS/CD278 Antibody (Feladilimab)
Featured Products
Feladilimab (Anti-ICOS/CD278 Reference Antibody (feladilimab); GSK3359609) is a humanized IgG4, anti-ICOS agonist monoclonal antibody. Feladilimab binds to ICOS-expressing T cells. Feladilimab has potential in cancer research.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145.52 kDa
Dry ice
2252518-85-5
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
GSK3359609, 88-2, 53-3
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q9Y6W8
Human
Unconjugated
Monoclonal
Protein A
IgG4PE
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human ICOS FC at 2 ug/mL can bind Anti-ICOS/CD278 Antibody (Feladilimab)
ICOS / CD278
Please avoid freeze-thaw cycles.